Analysis of disease-pathway by identifying susceptibility genes to primary biliary cirrhosis

Japanese Journal of Clinical Immunology

Volumn 35, Issue 6, 2012, Pages 503-510

  Makamura, Minoru ^a,b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

disease susceptibility gene; genomewide association study (GWAS); primary biliary cirrhosis (PBC); single nucleotide polymorphism (SNP)

Indexed keywords

EID: 84922687447     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.35.503     Document Type: Article

References (19)

1. Selmi C., Mayo M. J., Bach N., et al. : Primary biliary cirrhosis in monozygotic and dizygotic twins : Genetics, epigenetics, and environment. Gastroenterology 127 : 485–492, 2004.
2. Hirschfield G. M., Liu X., Xu C., et al. : Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants, N Engl J Med 360 : 2544–2555, 2009.
3. Hirschfield G. M., Liu X., Han Y., et al. : Variants at IRF5-TNPO3, 17q12–21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 42 : 655–657, 2010.
4. Liu X., Invernizzi P., Lu Y., et al. : Genomewide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 42 : 658–660, 2010.
5. Mells G. F., Floyd J. A. B., Morley K. I., et al. : Genomewide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 43 : 329–332, 2011.
6. Nakamura M., Nishida N., Kawashima M., et al. : Genomewide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet 91: 721–728, 2012.
7. Meylan F., Richard A. C., Siegel R. M. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol. Rev. 244 : 188–196, 2011.
8. Strober W and Fuss I J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1756–1767, 2011.
9. Goriely S., Neurath M. F., Goldman M. : How microorganisms tip the balance between interleukin 12 famkly members. Nat Rev Immunol 8 : 81–86, 2008.
10. van Wanrooij R. L., Zwiers A., Kraal G et al. : Genetic variations in interleukin-12 related genes in immune-mediated diseases. J Autoimmun, July 17, 2012. [Epub ahead of print]
11. Strubin M., Newell J. W., Matthias P. : OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80: 497–506, 1995.
12. Bartholdy, B., Du Roure, C., Bordon, A., et al. : The Ets factor Spi-B is a direct critical target of the coactivator OBF-1. Proc Natl Acad Sci USA 103 : 11665–11670, 2006.
13. Garrett-Sinha, L. A., Su., G. H., Rao, S., et al. : PU. 1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10 :399–408, 1999.
14. Cortes, M., Georgopoulos, K. : Aiolos is required for the generation of high affinity bone marrow plasma cells responsible for long-term immunity. J Exp Med 199 : 209–219, 2004.
15. Ma C. S., Deenick E. K., Batten M., et al. : The origins, function, and regulation of T follicular helper cells. J Exp Med 209 : 1241–1253, 2012.
16. Greenwald R. J., Freeman G. J., Sharpe A. H. : The B7 family revisited. Annu Rev Immunol. 23 : 515–548, 2005.
17. Mackall C., Fry T. J., Gress R. E. : Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 11: 330–342, 2011.
18. Yamazaki K., McGovern D., Ragoussis J., et al. : Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 14 : 3499–3506, 2005.
19. Yoshida K., Yang G. X., Zhang W., et al. : Deletion of interleukin-12–40 suppresses autoimmune cholangitis in dominant negative transforming factor beta receptor type II mice. Hepatology 50 : 1494–1500, 2009.